<h3>漲幅榜</h3>
<ul>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) 股票在週二的常規交易中上漲了 158.9%，至$0.34。其流通股的市場價值為 720 萬美元。</li>
<li><strong>Phio Pharma</strong> (NASDAQ: PHIO) 股票上漲了 51.11%，至$1.36。其流通股的市場價值為 960 萬美元。</li>
<li><strong>Evommune</strong> (NYSE: EVMN) 股票上漲了 44.7%，至$24.59。公司的市值為 5.355 億美元。</li>
<li><strong>Nektar Therapeutics</strong> (NASDAQ: NKTR) 股票上漲了 42.97%，至$53.0。公司的市值為 7.54 億美元。</li>
<li><strong>Abpro Hldgs</strong> (NASDAQ: ABP) 股票上漲了 27.63%，至$1.94。公司的市值為 410 萬美元。</li>
<li><strong>BiomX</strong> (AMEX: PHGE) 股票上漲了 24.7%，至$5.65。其流通股的市場價值為 690 萬美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) 股票在週二的常規交易中下跌了 33.0%，至$0.7。其流通股的市場價值為 920 萬美元。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 股票下跌了 25.79%，至$0.45。公司的市值為 210 萬美元。</li>
<li><strong>Tectonic Therapeutic</strong> (NASDAQ: TECX) 股票下跌了 20.96%，至$19.63。公司的市值為 4.647 億美元。</li>
<li><strong>Becton Dickinson</strong> (NYSE: BDX) 股票下跌了 17.38%，至$171.35。其流通股的市場價值為 590 億美元。根據新聞稿，第一季度的財報昨天發佈。</li>
<li><strong>Medpace Hldgs</strong> (NASDAQ: MEDP) 股票下跌了 14.95%，至$451.08。公司的市值為 149 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>Regenxbio</strong> (NASDAQ: RGNX) 股票下跌了 14.55%，至$8.81。公司的市值為 5.219 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

Medpace控股

EVMN

碧迪醫療

內克塔治療

PHIO

QNCX

<p>在週二的盤中交易中，Quince Therapeutics (NASDAQ:QNCX) 大幅上漲了 158.9%，達到 0.34 美元，而 Phio Pharma (NASDAQ:PHIO) 上漲了 51.11%，至 1.36 美元。其他顯著上漲的公司包括 Evommune (NYSE:EVMN) 上漲 44.7% 和 Nektar Therapeutics (NASDAQ:NKTR) 上漲 42.97%。相反，BioRestorative Therapies (NASDAQ:BRTX) 下降了 33.0%，Ensysce Biosciences (NASDAQ:ENSC) 下跌了 25.79%。Becton Dickinson (NYSE:BDX) 的股價下跌了 17.38%，至 171.35 美元，Medpace Hldgs (NASDAQ:MEDP) 在發佈第一季度財報後下跌了 14.95%</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅榜</h3>
</div><ul>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) stock increased by 158.9% to $0.34 during Tuesday's regular session. The market value of their outstanding shares is at $7.2 million.</li>
<li><strong>Phio Pharma</strong> (NASDAQ: PHIO) stock rose 51.11% to $1.36. The market value of their outstanding shares is at $9.6 million.</li>
<li><strong>Evommune</strong> (NYSE: EVMN) stock moved upwards by 44.7% to $24.59. The company's market cap stands at $535.5 million.</li>
<li><strong>Nektar Therapeutics</strong> (NASDAQ: NKTR) shares increased by 42.97% to $53.0. The company's market cap stands at $754.0 million.</li>
<li><strong>Abpro Hldgs</strong> (NASDAQ: ABP) shares rose 27.63% to $1.94. The company's market cap stands at $4.1 million.</li>
<li><strong>BiomX</strong> (AMEX: PHGE) stock moved upwards by 24.7% to $5.65. The market value of their outstanding shares is at $6.9 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) 股票在週二的常規交易中上漲了 158.9%，至$0.34。其流通股的市場價值為 720 萬美元。</li>
<li><strong>Phio Pharma</strong> (NASDAQ: PHIO) 股票上漲了 51.11%，至$1.36。其流通股的市場價值為 960 萬美元。</li>
<li><strong>Evommune</strong> (NYSE: EVMN) 股票上漲了 44.7%，至$24.59。公司的市值為 5.355 億美元。</li>
<li><strong>Nektar Therapeutics</strong> (NASDAQ: NKTR) 股票上漲了 42.97%，至$53.0。公司的市值為 7.54 億美元。</li>
<li><strong>Abpro Hldgs</strong> (NASDAQ: ABP) 股票上漲了 27.63%，至$1.94。公司的市值為 410 萬美元。</li>
<li><strong>BiomX</strong> (AMEX: PHGE) 股票上漲了 24.7%，至$5.65。其流通股的市場價值為 690 萬美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) shares declined by 33.0% to $0.7 during Tuesday's regular session. The market value of their outstanding shares is at $9.2 million.</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) shares fell 25.79% to $0.45. The company's market cap stands at $2.1 million.</li>
<li><strong>Tectonic Therapeutic</strong> (NASDAQ: TECX) shares decreased by 20.96% to $19.63. The company's market cap stands at $464.7 million.</li>
<li><strong>Becton Dickinson</strong> (NYSE: BDX) shares declined by 17.38% to $171.35. The market value of their outstanding shares is at $59.0 billion. As per the press release, Q1 earnings came out yesterday.</li>
<li><strong>Medpace Hldgs</strong> (NASDAQ: MEDP) stock fell 14.95% to $451.08. The company's market cap stands at $14.9 billion. As per the press release, Q4 earnings came out yesterday.</li>
<li><strong>Regenxbio</strong> (NASDAQ: RGNX) stock fell 14.55% to $8.81. The company's market cap stands at $521.9 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) 股票在週二的常規交易中下跌了 33.0%，至$0.7。其流通股的市場價值為 920 萬美元。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 股票下跌了 25.79%，至$0.45。公司的市值為 210 萬美元。</li>
<li><strong>Tectonic Therapeutic</strong> (NASDAQ: TECX) 股票下跌了 20.96%，至$19.63。公司的市值為 4.647 億美元。</li>
<li><strong>Becton Dickinson</strong> (NYSE: BDX) 股票下跌了 17.38%，至$171.35。其流通股的市場價值為 590 億美元。根據新聞稿，第一季度的財報昨天發佈。</li>
<li><strong>Medpace Hldgs</strong> (NASDAQ: MEDP) 股票下跌了 14.95%，至$451.08。公司的市值為 149 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>Regenxbio</strong> (NASDAQ: RGNX) 股票下跌了 14.55%，至$8.81。公司的市值為 5.219 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週二盤中交易中出現波動